By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BioTime, Inc. 

1301 Harbor Bay Parkway

Alameda  California  94502  U.S.A.
Phone: 510-521-3390 Fax: 510-521-3389


Key Statistics

Ownership: Public

Web Site: BioTime
Symbol: BTX

Company News
First Patient Cohort Data From BioTime (BTX)'s OpRegen Clinical Trial In Dry-AMD To Be Presented At ISOPT Clinical Symposium On December 2, 2016 10/20/2016 1:22:16 PM
BioTime (BTX) To Present At The BIO Investor Forum 10/13/2016 11:49:44 AM
BioTime (BTX) To Webcast Presentation At The Ladenburg Thalmann 2016 Healthcare Conference 9/23/2016 10:38:03 AM
BioTime (BTX) Affiliate, Asterias Biotherapeutics, Announced Positive Interim Efficacy Data From Trial In Patients With Complete Cervical Spinal Cord Injuries 9/16/2016 11:38:44 AM
BioTime (BTX) To Present At Two Upcoming Investor Conferences 9/6/2016 11:21:48 AM
BioTime (BTX) Announces Issuance Of 31 New Patents To Strengthen Its Patent Portfolio In Regenerative Medicine 8/15/2016 11:51:14 AM
BioTime (BTX) Reports Second Quarter Results And Recent Corporate Accomplishments 8/10/2016 11:11:44 AM
BioTime (BTX) To Report Second Quarter Results On August 9, 2016 7/27/2016 9:34:57 AM
BioTime (BTX) Announces Full Exercise And Closing Of Underwriters’ Over-Allotment Option 7/5/2016 10:52:41 AM
BioTime (BTX) Presents Online Resource For Applying Artificial Intelligence To Stem Cell Biology At Mensa 2016 Annual Gathering 6/29/2016 9:17:33 AM